Isabelle Rochat

Publications | Mémoires et thèses

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil


48 publications

2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2015 | 2014 | 2013 | 2012 | 2011 | 2008 | 2006 | 2004 |
 
Early nasal microbiota and subsequent respiratory tract infections in infants with cystic fibrosis.
Steinberg R., Mostacci N., Kieninger E., Frauchiger B., Casaulta C., Usemann J., Moeller A., Trachsel D., Rochat I., Blanchon S. et al., 2024/11/23. Communications medicine, 4 (1) p. 246. Peer-reviewed.
Lung structural and functional impairments in young children with cystic fibrosis diagnosed following newborn screening - A nationwide observational study.
Frauchiger B.S., Willers C., Cotting J., Kieninger E., Korten I., Casaulta C., Salem Y., Stranzinger E., Brabandt B., Usemann J. et al., 2024/09. Journal of cystic fibrosis, 23 (5) pp. 910-917. Peer-reviewed.
Data accuracy, consistency and completeness of the national Swiss cystic fibrosis patient registry: Lessons from an ECFSPR data quality project.
Wolf L., Usemann J., Collaud E., Derkenne M.F., Fischer R., Hensen M., Hitzler M., Hofer M., Inci D., Irani S. et al., 2024/05. Journal of cystic fibrosis, 23 (3) pp. 506-511. Peer-reviewed.
 
Obstruction laryngée induite à l’effort: méthodes diagnostiques et prise en charge [Exercise-induced laryngeal obstruction : diagnosis and management]
Glasson N., Diserens L., Besson C., Raemy A., Rochat Guignard I., Todic J., 2024/02/28. Revue medicale suisse, 20 (863) pp. 453-457. Peer-reviewed.
Case Report: When cystic fibrosis, elexacaftor/tezacaftor/ivacaftor therapy, and alpha1 antitrypsin deficiency get together.
Kinuani R., Ezri J., Kernen Y., Rochat I., Blanchon S., 2024. Frontiers in pediatrics, 12 p. 1378744. Peer-reviewed.
Correction to: New Dominant‑Negative IL6ST Variants Expand the Immunological and Clinical Spectrum of GP130‑Dependent Hyper‑IgE Syndrome.
Arlabosse T., Materna M., Riccio O., Schnider C., Angelini F., Perreau M., Rochat I., Superti-Furga A., Campos-Xavier B., Héritier S. et al., 2023/10. Journal of clinical immunology, 43 (7) p. 1674. Peer-reviewed.
New Dominant-Negative IL6ST Variants Expand the Immunological and Clinical Spectrum of GP130-Dependent Hyper-IgE Syndrome.
Arlabosse T., Materna M., Riccio O., Schnider C., Angelini F., Perreau M., Rochat I., Superti-Furga A., Campos-Xavier B., Héritier S. et al., 2023/10. Journal of clinical immunology, 43 (7) pp. 1566-1580. Peer-reviewed.
 
Recommandations suisses pour le diagnostic, le traitement et la prise en charge de l'asthme de l'enfant dès l'âge de 5 ans
Möller Alexander, Barazzone Constance, Barben Juerg, Blanchon Sylvain, Hammer Juerg, Latzin Philipp, Rochat Guignard Isabelle, Salfeld Peter, Trachsel Daniel, Zanolari Maura et al., 2023/09/30. Paediatrica, 34 (3).
 
Recommandations suisses pour le diagnostic, le traitement et la prise en charge des maladies respiratoires obstructives du petit enfant en âge préscolaire de 1 à 4 ans
Regamey Nicolas, Barazzone Constance, Barben Juerg, Blanchon Sylvain, Hammer Juerg, Latzin Philipp, Rochat Guignard Isabelle, Salfeld Peter, Trachsel Daniel, Zanolari Maura et al., 2023/09/30. Paediatrica, 34 (3).
 
Feasibility of unsedated lung MRI in young children with cystic fibrosis.
Willers C.C., Frauchiger B.S., Stranzinger E., Bauman G., Moeller A., Jung A., Hector A., Regamey N., Zanolari M., Mueller-Suter D. et al., 2022/11. The European respiratory journal, 60 (5) p. 2103112. Peer-reviewed.
Determinants of lung function changes in athletic swimmers. A review.
Rochat I., Côté A., Boulet L.P., 2022/02. Acta paediatrica, 111 (2) pp. 259-264. Peer-reviewed.
Respiratory symptoms do not reflect functional impairment in early CF lung disease.
Korten I., Oestreich M.A., Frey U., Moeller A., Jung A., Spinas R., Mueller-Suter D., Trachsel D., Rochat I., Spycher B. et al., 2021/11. Journal of cystic fibrosis, 20 (6) pp. 957-964. Peer-reviewed.
A Comprehensive Approach for the Diagnosis of Primary Ciliary Dyskinesia-Experiences from the First 100 Patients of the PCD-UNIBE Diagnostic Center.
Müller L., Savas S.T., Tschanz S.A., Stokes A., Escher A., Nussbaumer M., Bullo M., Kuehni C.E., Blanchon S., Jung A. et al., 2021/08/25. Diagnostics, 11 (9) p. 1540. Peer-reviewed.
 
CFTR-function and ventilation inhomogeneity in individuals with cystic fibrosis.
Bernasconi N., Kieninger E., Shaw M., Kurz J., Moeller A., Ratjen F., Rochat I., Stanojevic S., Singer F., 2021/07. Journal of cystic fibrosis, 20 (4) pp. 641-647. Peer-reviewed.
Prevalence and risk factors of lactic acidosis in children with acute moderate and severe asthma, a prospective observational study.
Ruman-Colombier M., Rochat Guignard I., Di Paolo E.R., Gehri M., Pauchard J.Y., 2021/04. European journal of pediatrics, 180 (4) pp. 1125-1131. Peer-reviewed.
Chlamydia pneumoniae and Mycoplasma pneumoniae in children with cystic fibrosis: impact on bacterial respiratory microbiota diversity.
Pittet L.F., Bertelli C., Scherz V., Rochat I., Mardegan C., Brouillet R., Jaton K., Mornand A., Kaiser L., Posfay-Barbe K. et al., 2021/01/06. Pathogens and disease, 79 (1) pp. ftaa074. Peer-reviewed.
 
COVID-19: A message of hope from a young girl with severe cystic fibrosis.
Blanchon S., Fernandez C., Guerin S., Crisinel P.A., Rochat I., 2020/07. Pediatric pulmonology, 55 (7) pp. 1546-1547. Peer-reviewed.
Prevalence of tuberculosis in migrant children in Switzerland and relevance of current screening guidelines.
Boukamel M., Fougère Y., Gehri M., Suris J.C., Rochat I., Miletto D., Kyrilli S., Fouriki A., Crisinel P.A., 2020/06/01. Swiss medical weekly, 150 pp. w20253. Peer-reviewed.
Monoacylglycerol Form of Omega-3s Improves Its Bioavailability in Humans Compared to Other Forms.
Cuenoud B., Rochat I., Gosoniu M.L., Dupuis L., Berk E., Jaudszus A., Mainz J.G., Hafen G., Beaumont M., Cruz-Hernandez C., 2020/04/07. Nutrients, 12 (4) p. 1014. Peer-reviewed.
 
Atypical pulmonary lesion in a young patient: One train may hide another, do not forget tuberculosis.
Pittet L.F., Rochat I., Simoni C., Tooh M.M., Gengler C., Crisinel P.A., 2020/02. Pediatric pulmonology, 55 (2) pp. 278-279. Peer-reviewed.
 
Prescriptions for treatment in patients with PCD: does clinical routine match recommendations?
Collaud E. N. R., Wisse A., Pedersen E. S. L., Juerg B., Clarenbach C., Jung A., Latzin P., Lazor R., Marco L., Rochat I. et al., 2020. dans European Respiratory Journal.
 
One-year outcomes in a multicentre cohort study of incident rare diffuse parenchymal lung disease in children (ChILD).
Cunningham S, Graham C, MacLean M, Aurora P, Ashworth M, Barbato A, Calder A, Carlens J, Clement A, Hengst M et al., 2019/11. Thorax.
Dyspnée d’effort chez l’adolescent [Exercise induced dyspnea in adolescents]
Saubade M., Chiari M., Guinchard A.C., Rochat I., 2019/07/10. Revue medicale suisse, 15 (657) pp. 1310-1317. Peer-reviewed.
 
Pneumocystis jirovecii Pneumonia in an Infant: The Tip of the Iceberg.
Boillat L., Angelini F., Crucis-Armengaud A., Asner S.A., Rochat I., 2019/05. Clinical pediatrics, 58 (5) pp. 578-581. Peer-reviewed.
No benefit of longer eradication therapy of Pseudomonas aeruginosa primoinfections in pediatric cystic fibrosis.
Claude F., Rochat I., Hafen G.M., 2019/03. BMC research notes, 12 (1) p. 115.
 
RSNA 2018 PD164-ED-X | Children Interstitial Lung Disease (chILD): A Hint for the Radiologist
Pichon N., Crivelli L., Rochat I., Alamo L., Tenisch E., Berteloot L., 2018/11/25., RSNA 2018 104rd Scientific Assembly and Annual Meeting. Nov 25-30 2018, dans 104rd Scientific Assembly and Annual Meeting. Nov 25-30 2018, McCornick Place, Chicago, IL. Poster All Day. Peer-reviewed.
 
Alternate gas washout indices: Assessment of ventilation inhomogeneity in mild to moderate pediatric cystic fibrosis lung disease.
Nyilas S., Bigler A., Yammine S., Kieninger E., Rochat I., Ramsey K., Casaulta C., Moeller A., Latzin P., Singer F., 2018/11. Pediatric pulmonology, 53 (11) pp. 1485-1491. Peer-reviewed.
 
«Docteur, mon enfant a bu la tasse, peut-il mourir d’une noyade sèche ? » [« Doctor, my child swallowed water, can he die from dry drowning ? » An update on drowning in 2018]
Scartezzini K., Greyo S., Daigle V., Rochat I., Villoslada J., 2018/09/05. Revue medicale suisse, 14 (617) pp. 1565-1567. Peer-reviewed.
 
Lower exhaled nitric oxide in infants with Cystic Fibrosis compared to healthy controls.
Korten I., Liechti M., Singer F., Hafen G., Rochat I., Anagnostopoulou P., Müller-Suter D., Usemann J., Moeller A., Frey U. et al., 2018/01. Journal of cystic fibrosis, 17 (1) pp. 105-108. Peer-reviewed.
 
Elevated lung clearance index in infants with cystic fibrosis shortly after birth.
Kieninger E., Yammine S., Korten I., Anagnostopoulou P., Singer F., Frey U., Mornand A., Zanolari M., Rochat I., Trachsel D. et al., 2017/11. The European respiratory journal, 50 (5) pp. NA. Peer-reviewed.
 
International management platform for children's interstitial lung disease (chILD-EU).
Griese M, Seidl E, Hengst M, Reu S, Rock H, Anthony G, Kiper N, Emiralioğlu N, Snijders D, Goldbeck L et al., 2017/10. Thorax.
 
Bilateral Dacryoadenitis: Don't Forget Tuberculosis!
Ruman-Colombier M., Crisinel P.A., Cohen-Dumani N., Ceschi G., Rochat Guignard I., 2017/01. The Pediatric infectious disease journal, 36 (1) pp. 117-119. Peer-reviewed.
 
Death after cessation of treatment by cystic fibrosis patients: An international survey of clinicians.
Pisaturo M., Deppen A., Rochat I., Robinson W.M., Hafen G.M., 2017/01. Palliative medicine, 31 (1) pp. 82-88. Peer-reviewed.
Stop using the flotation technique and start weighing salbutamol pressurised metered-dose inhalers without dose counters.
Di Paolo E.R., Spaggiari S., Pannatier A., Sadeghipour F., Rochat I., Hafen G.M., 2015. Swiss Medical Weekly, 145 pp. w14162. Peer-reviewed.
Idiopathic desquamative interstitial pneumonia in a child: a case report.
Bressieux-Degueldre S., Rotman S., Hafen G., Aubert J.D., Rochat I., 2014/06/22. BMC research notes, 7 p. 383. Peer-reviewed.
 
Ancien prématuré avec dysplasie bronchopulmonaire: quelle prise en charge en 2014 [Former preterm infant with bronchopulmonary dysplasia: how will this be cared for in 2014?].
Mornand A., Roth-Kleiner M., Hafen G., Argiroffo C.B., Rochat I., 2014/02. Revue Médicale Suisse, 10 (418) pp. 430-434. Peer-reviewed.
 
Chest CT in bronchopulmonary dysplasia: clinical and radiological correlations.
Tonson la Tour A., Spadola L., Sayegh Y., Combescure C., Pfister R., Argiroffo C.B., Rochat I., 2013/07. Pediatric pulmonology, 48 (7) pp. 693-698. Peer-reviewed.
 
Pédiatrie. 2. Traitement de la bronchiolite aiguë du nourrisson [Pediatrics. New treatment options for viral bronchiolitis].
Rochat I., Hafen G., 2013/01. Revue Médicale Suisse, 9 (369) pp. 134-135.
Chest physiotherapy using passive expiratory techniques does not reduce bronchiolitis severity: a randomised controlled trial.
Rochat I., Leis P., Bouchardy M., Oberli C., Sourial H., Friedli-Burri M., Perneger T., Barazzone Argiroffo C., 2012. European Journal of Pediatrics, 171 (3) pp. 457-462.
Erratum to: Chest physiotherapy using passive expiratory techniques does not reduce bronchiolitis severity: a randomised controlled trial
Rochat I., Leis P., Bouchardy M., Oberli C., Sourial H., Friedli-Burri M., Perneger T., Barazzone Argiroffo C., Perneger Thomas, Argiroffo Constance Barazzone, 2012. European Journal of Pediatrics, 171 (3) p. 603.
 
Vade-mecum mucoviscidose en pédiatrie pour le CHUV et le HUG
Hafen G., Rochat I., Kernen Y., 2012..
Exhaled nitric oxide decreases after positive food-allergen challenge.
Benhamou A.H., Koehli A., Rochat I., Inci D., Moeller A., Taramarcaz P., Lauener R.P., Eigenmann P.A., 2011/11/28. Clinical and translational allergy, 1 (1) p. 14. Peer-reviewed.
 
Early blood exchange transfusion in malignant pertussis: A case report.
Martinez M., Rochat I., Corbelli R., Tissières P., Rimensberger P.C., Barazzone-Argiroffo C., 2011. Pediatric Critical Care Medicine, 12 (2) pp. e107-e109.
 
Correlation of lung abnormalities on high-resolution CT with clinical graft-versus-host disease after allogeneic versus autologous bone marrow transplantation in children.
Merlini L., Borzani I.M., Anooshiravani M., Rochat I., Ozsahin A.H., Hanquinet S., 2008/11. Pediatric radiology, 38 (11) pp. 1201-1209. Peer-reviewed.
 
Comment investiguer les troubles respiratoires du sommeil chez l'enfant? [How to investigate sleep related breathing disorders in children?]
Rochat I., Guinand S., Barazzone C., Hafen G., 2008/02/27. Revue medicale suisse, 4 (146) pp. 515,517-518,520-522. Peer-reviewed.
 
Bronchoalveolar cytology for diagnosing pulmonary GVHD after bone marrow transplant in children.
Rochat I., Posfay-Barbe K.M., Kumar N., Pache J.C., Kaiser L., Ozsahin H., Barazzone Argiroffo C., Bongiovanni M., 2008. Pediatric Pulmonology, 43 (7) pp. 697-702.
 
CR7/102--Left colonic perforation as the initial presentation of CF disease in the neonatal period.
Rochat I, Marcotte JE, Fournet JC, Ouimet A, Yasbeck S, Laberge S, 2006/01. Paediatric respiratory reviews.
 
Acute hypoxic respiratory failure as the first manifestation of systemic-onset juvenile rheumatoid arthritis in a child.
Rochat I., Sayegh Y., Gervaix A., Rimensberger P.C., Argiroffo C.B., 2004/12. Pediatric pulmonology, 38 (6) pp. 483-487. Peer-reviewed.
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Swiss University